1. General
  2. Others

  3. Others

Cipla cuts prices on 3 anti-cancer drugs: reports

India Infoline News Service | Mumbai | November 08, 2012 12:51 IST

Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.

Drug maker Cipla has reduced the prices on three anti-cancer drugs — Erlotinib (ERLOCIP), Docetaxel (DOCETAX) and Capecitabine (CAPEGARD), according to reports.

Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.

BSE 625.30 [4.35] ([0.69]%)
NSE 625.10 [5] ([0.79]%)

***Note: This is a BSE Chart









article
113110704863
Cipla cuts prices on 3 anti-cancer drugs: reports
Cipla cuts prices on 3 anti-cancer drugs: reports
Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.
http://www.indiainfoline.com/article/news-top-story/cipla-cuts-prices-on-3-anti-cancer-drugs-reports-113110704863_1.html
November 08, 2012 12:51 IST
http://content.indiainfoline.com/_media/iifl/img/article/default/glo_news.jpg
Cipla
Others
$rawVideoFileUrl$
$videoPlayerUrl$
 

 
 
Reports
News